424 related articles for article (PubMed ID: 16966714)
1. Biotech drugs come of age; policymakers take notice.
Iglehart JK
Health Aff (Millwood); 2006; 25(5):1202-3. PubMed ID: 16966714
[No Abstract] [Full Text] [Related]
2. Biotech's billion dollar breakthrough.
Stipp D
Fortune; 2003 May; 147(10):96-8, 100, 103. PubMed ID: 12776500
[No Abstract] [Full Text] [Related]
3. Genomic sciences and the medicine of tomorrow.
Drews J
Nat Biotechnol; 1996 Nov; 14(11):1516-8. PubMed ID: 9634812
[No Abstract] [Full Text] [Related]
4. The promise of pharmacogenetics: assessing the prospects for disease and patient stratification.
Smart A; Martin P
Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):583-601. PubMed ID: 16980196
[TBL] [Abstract][Full Text] [Related]
5. The market for follow-on biologics: how will it evolve?
Grabowski H; Cockburn I; Long G
Health Aff (Millwood); 2006; 25(5):1291-301. PubMed ID: 16966725
[TBL] [Abstract][Full Text] [Related]
6. Biotech industry tries to recover from 2-year lull.
Brower V
J Natl Cancer Inst; 2003 Mar; 95(5):348-9. PubMed ID: 12618496
[No Abstract] [Full Text] [Related]
7. What's fueling the biotech engine?
Aggarwal S
Nat Biotechnol; 2007 Oct; 25(10):1097-104. PubMed ID: 17921989
[No Abstract] [Full Text] [Related]
8. Biotech R&D still reeling.
Lawrence S
Nat Biotechnol; 2004 Sep; 22(9):1068. PubMed ID: 15340460
[No Abstract] [Full Text] [Related]
9. The further evolution of biotech.
Nagle T; Berg C; Nassr R; Pang K
Nat Rev Drug Discov; 2003 Jan; 2(1):75-9. PubMed ID: 12509762
[TBL] [Abstract][Full Text] [Related]
10. R&D deals boom in 2004.
Lawrence S
Nat Biotechnol; 2005 Sep; 23(9):1036. PubMed ID: 16151383
[No Abstract] [Full Text] [Related]
11. The biotech drug market.
Lawrence S
Nat Biotechnol; 2004 Dec; 22(12):1496. PubMed ID: 15583645
[No Abstract] [Full Text] [Related]
12. Biotech jostles with pharma for slice of HIV market.
Katsnelson A
Nat Biotechnol; 2006 Jan; 24(1):3-4. PubMed ID: 16404375
[No Abstract] [Full Text] [Related]
13. Little biotech on the prairie.
Wolfson W
Chem Biol; 2007 Sep; 14(9):969-71. PubMed ID: 17884626
[No Abstract] [Full Text] [Related]
14. Biotech at the beauty counter.
Nasto B
Nat Biotechnol; 2007 Jun; 25(6):617-9. PubMed ID: 17557090
[No Abstract] [Full Text] [Related]
15. Overcoming the obstacles in the pharma/biotech industry: 2008 update.
Graul AI; Revel L; Rosa E; Cruces E
Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298
[TBL] [Abstract][Full Text] [Related]
16. Overcoming further challenges in the pharma/biotech industry: 2007 update.
Graul AI; Cruces E; Revel L; Serradell N; Rosa E
Drug News Perspect; 2008; 21(1):44-58. PubMed ID: 18301809
[TBL] [Abstract][Full Text] [Related]
17. Bugs or drugs, tortoises or hares?
Jacobs T
Nat Biotechnol; 2005 Mar; 23(3):293. PubMed ID: 15765079
[No Abstract] [Full Text] [Related]
18. Shutters come off IPO window.
Hodgson J
Nat Biotechnol; 2002 Jan; 20(1):6. PubMed ID: 11753342
[No Abstract] [Full Text] [Related]
19. Can personalized drugs pay off?
Stipp D
Fortune; 2002 May; 145(10):168. PubMed ID: 12025349
[No Abstract] [Full Text] [Related]
20. Overcoming the challenges in the pharma/biotech industry.
Graul AI; Prous JR
Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
